CLOVClover Health Investments, Corp.

$4.81+39% 1Y

The financials

Clover Health Investments, Corp. by the numbers

Clover Health Investments, Corp. (CLOV) reported revenue of $759M in Q3 2026 (quarter ended Sep 30, 2026), up 53% from the same quarter a year earlier. That came with net income of $6.4M (0.8% of revenue). For the full year FY2025, revenue was $1.92B (+40% year on year) with a net loss of $86M. Its largest segment in Q2 2025 (quarter ended Jun 30, 2025) was Insurance at $16M, 50.0% of the disclosed total, just ahead of Insurance at 50.0%. The next results filing is expected around Feb 3, 2027, a quarter after the last one.

Clover Health Investments, Corp. income statement, Q3 2026 against the same quarter a year earlier
Income statementQ3 2026Q3 2025Change
Revenue$759M$497M+53%
Operating income$6.4M−$24Mto a profit
Net income$6.4M−$24Mto a profit
Diluted EPS$0.01−$0.05to a profit
Revenue by segment, Q2 2025 (quarter ended Jun 30, 2025), as reported to the SEC · segment disclosure runs one filing behind the income statement
OperatingRevenueShare
Insurance$16M50%
Insurance$16M50%

Business segments

Revenue split by operating segment, from SEC XBRL filings.

Latest period: Q3 2026Total $24.6M (-2.5%)
Insurance grew +358% year on year
  • Insurance$24.6Mvs last quarter -2.5%vs a year ago +358%
Segment sum = 3% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed Nov 6, 2026, SEC EDGAR
Clover Health Investments (CLOV) Revenue, Earnings and Segments · Ryufin